Literature DB >> 33395745

PRRX1 promotes malignant properties in human osteosarcoma.

Ryoji Joko1, Daisuke Yamada2, Masahiro Nakamura3, Aki Yoshida4, Shota Takihira1, Tomoka Takao2, Ming Lu2, Kohei Sato4, Tatsuo Ito5, Toshiyuki Kunisada4, Eiji Nakata4, Toshifumi Ozaki4, Takeshi Takarada6.   

Abstract

Paired related homeobox 1 (PRRX1) is a marker of limb bud mesenchymal cells, and deficiency of p53 or Rb in Prrx1-positive cells induces osteosarcoma in several mouse models. However, the regulatory roles of PRRX1 in human osteosarcoma have not been defined. In this study, we performed PRRX1 immunostaining on 35 human osteosarcoma specimens to assess the correlation between PRRX1 level and overall survival. In patients with osteosarcoma, the expression level of PRRX1 positively correlated with poor prognosis or the ratio of lung metastasis. Additionally, we found PRRX1 expression on in 143B cells, a human osteosarcoma line with a high metastatic capacity. Downregulation of PRRX1 not only suppressed proliferation and invasion but also increased the sensitivity to cisplatin and doxorubicin. When 143B cells were subcutaneously transplanted into nude mice, PRRX1 knockdown decreased tumor sizes and rates of lung metastasis. Interestingly, forskolin, a chemical compound identified by Connectivity Map analysis using RNA expression signatures during PRRX1 knockdown, decreased tumor proliferation and cell migration to the same degree as PRRX1 knockdown. These results demonstrate that PRRX1 promotes tumor malignancy in human osteosarcoma.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Connectivity map analysis; Drug resistance; Invasion; Osteosarcoma; PRRX1; Tumor malignancy

Year:  2020        PMID: 33395745     DOI: 10.1016/j.tranon.2020.100960

Source DB:  PubMed          Journal:  Transl Oncol        ISSN: 1936-5233            Impact factor:   4.243


  3 in total

1.  Risk Factors, Prognostic Factors, and Nomograms for Distant Metastasis in Patients With Newly Diagnosed Osteosarcoma: A Population-Based Study.

Authors:  Bo Chen; Yuan Zeng; Bo Liu; Gaoxiang Lu; Zhouxia Xiang; Jiyang Chen; Yan Yu; Ziyi Zuo; Yangjun Lin; Jinfeng Ma
Journal:  Front Endocrinol (Lausanne)       Date:  2021-07-30       Impact factor: 5.555

2.  TPX2 regulated by miR-29c-3p induces cell proliferation in osteosarcoma via the AKT signaling pathway.

Authors:  Dongsheng Zhu; Xiangfei Xu; Ming Zhang; Tong Wang
Journal:  Oncol Lett       Date:  2022-03-11       Impact factor: 2.967

3.  PRRX1 Is a Novel Prognostic Biomarker and Facilitates Tumor Progression Through Epithelial-Mesenchymal Transition in Uveal Melanoma.

Authors:  Zhishang Meng; Yanzhu Chen; Wenyi Wu; Bin Yan; Lusi Zhang; Huihui Chen; Yongan Meng; Youling Liang; Xiaoxi Yao; Jing Luo
Journal:  Front Immunol       Date:  2022-02-25       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.